bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

BIAF announced a $4 million registered direct common-stock financing and a concurrent private placement, both priced at-the-market under Nasdaq rules. The headline provides no further details on the placement terms or use of proceeds.